Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3 eBioMedicine Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect . , One of the biggest mistakes I see is assuming that if someone cannot tolerate a GLP 1, there are no other options. Thats You thought Ozempic was big? Just wait. The next generation of weight loss medications is already in clinical trials oral pills, monthly injections, and even triple action drugs that may work better than Development of Cagrilintide, a Long Acting Amylin Analogue Journal of Medicinal Chemistry